Literature DB >> 27917722

Racial disparities in papillary thyroid microcarcinoma survival.

U C Megwalu1, A T Saini2.   

Abstract

OBJECTIVE: To evaluate the impact of race on survival in patients with papillary thyroid microcarcinoma.
METHODS: The study cohort included 17 668 patients diagnosed with papillary thyroid microcarcinoma between 1988 and 2009, identified in the Surveillance, Epidemiology, and End Results 18 database of the National Cancer Institute.
RESULTS: Black patients had lower overall survival than other racial groups (p < 0.001). Black patients had significantly worse overall survival (hazard ratio = 2.59) after adjusting for sex, marital status, age, year of diagnosis, multifocal disease and type of surgery. A subset analysis of Black patients revealed no significant difference in overall survival for total thyroidectomy versus lobectomy (p = 0.15).
CONCLUSION: Black race is a negative prognostic factor in thyroid cancer, which cannot be explained by advanced disease stage. Further research on mechanisms by which race affects survival is needed to reveal areas of opportunity for interventions aimed at reducing health disparities in cancer care.

Entities:  

Keywords:  Health Status Disparities; Minority Health; SEER Program; Thyroid Neoplasms

Mesh:

Year:  2016        PMID: 27917722     DOI: 10.1017/S0022215116009737

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.

Authors:  Zachary Hurst; Sandya Liyanarachchi; Huiling He; Pamela Brock; Jennifer Sipos; Fadi Nabhan; Electron Kebebew; Patience Green; Gilbert J Cote; Steven Sherman; Christopher J Walker; Yi Seok Chang; Shuai Xue; Brynn Hollingsworth; Wei Li; Luke Genutis; Eric Menq; Albert de la Chapelle; Sissy M Jhiang
Journal:  Thyroid       Date:  2019-02-13       Impact factor: 6.568

2.  Gender and Racial Disparities in Survival After Surgery Among Papillary and Patients With Follicular Thyroid Cancer: A 45-Year Experience.

Authors:  Ammar Asban; Sebastian K Chung; Rongbing Xie; Brenessa M Lindeman; Courtney J Balentine; James K Kirklin; Herbert Chen
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-09-25

3.  Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos.

Authors:  Uchechukwu C Megwalu; Yifei Ma; Nosayaba Osazuwa-Peters; Lisa A Orloff
Journal:  Cancer Med       Date:  2021-07-21       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.